Searched for
NORTH AMERICA DRUG MARKET
For Nestle, India a growth outlier across marketsNestle SA has reported impressive growth in India, a significant market for the company. The packaged food giant achieved double-digit real...- Cipla expects sequential recovery in North America on new product launches despite tariff uncertaintyCipla reported a 39% drop in net profit to ₹789 crore for the June quarter due to weakness in its North America business and margin compres...
- Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says reshoring not practicalUS President Trump's proposed tariffs on imported generic drugs will not immediately affect Indian drugmakers. Indian companies export sign...
- Dr Reddy’s aims to resume semaglutide supply by November after API fixDr Reddy's expects to resume semaglutide supplies by November after resolving quality issues. The company identified the root cause and pla...
- 'I expect India to be concerned about US pharma tariffs': Rubio on Trump's 200% stormUS Secretary of State Marco Rubio anticipates Indian concern over new generic drug import tariffs. These tariffs will rise significantly af...
- Tariffs alone will not produce sustainable generic medicine in US: IPAThe Indian Pharmaceutical Alliance believes tariffs alone will not build US generic drug manufacturing. Broader reforms are needed for fair...
- FBI issues 'wanted' notice for Indian national in drug trafficking caseThe FBI has launched a search for Harmanveer Singh following "Operation Hard Ball", an international crackdown on India-linked crime syndic...
- Generic drugmaker Sandoz to engage with US after Trump tariff threatUS President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face signific...
- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Glenmark gets USFDA nod for expanded use of RYALTRIS nasal sprayGlenmark Pharmaceuticals announced US FDA approval for RYALTRIS nasal spray. This approval expands its use to children aged six to twelve y...
- Why are wildfires becoming more frequent across North America? Causes explainedNorth America wildfires explained: North America faces an intense fire season with millions of acres already burned. Climate change drives ...
- Garware Fulflex acquires 300,000-Sq-Ft automated US medical facilityGarware Fulflex has acquired a large medical products manufacturing facility in Texas. This acquisition significantly expands their North A...
- OnePlus exits Europe, North America as the 'flagship killer' fights for relevanceOnePlus is withdrawing from Europe and North America as part of a global strategy adjustment. This move follows reports of parent company O...
- PepsiCo's turnaround stutters as Americans rethink snackingPepsiCo's North American food business sees sales slip as consumers shift eating habits. GLP-1 drug use and rising costs influence purchasi...
Load More
